Tomas Olsson

Also affiliated with Karolinska Institutet, Swedish e-Science Research Centre, Centre for Palaeogenetics

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 11 papers. Top paper: “Locus for severity implicates CNS resilience in progression of multiple sclerosis”.

Locus for severity implicates CNS resilience in progression of multiple sclerosis

Nature(2023)10.1038/s41586-023-06250-x

N/A

3.3DataRank · unranked

236 citations

Pernilla Stridh, Jacob L. McCauley, Janna Saarela, Aletta M.R. van den Bosch, Hendrik J. Engelenburg +95 more

Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis

Nature(2011)10.1038/nature10251

N/A

1.2DataRank · unranked

2729 citations

Stephen Sawcer, Garrett Hellenthal, Matti Pirinen, Chris C. A. Spencer, Nikolaos A. Patsopoulos +241 more

Treatment- and population-specific genetic risk factors for anti-drug antibodies against interferon-beta: a GWAS

BMC Medicine(2020)10.1186/s12916-020-01769-6

N/A

0.877DataRank · unranked

19 citations

Jenny Link, Dorothea Martin, Malin Ryner, Christina Hermanrud, Verena Grummel +16 more

Evidence supports a causal association between allele-specific vitamin D receptor binding and multiple sclerosis among Europeans

Proceedings of the National Academy of Sciences(2024)10.1073/pnas.2302259121

N/A

0.413DataRank · unranked

9 citations

Ali Manouchehrinia, Hong Quach, Diana Quach, Tomas Olsson, Ingrid Kockum +5 more

COVID‐19 clinical outcomes and DMT of MS patients and population‐based controls

Annals of Clinical and Translational Neurology(2022)10.1002/acn3.51646

N/A

0DataRank · unranked

17 citations

Hannah Bower, Kyla A. McKay, Simon Englund, Joachim Burman, Katharina Fink +13 more

Seroreactivity against lytic, latent and possible cross-reactive EBV antigens appears on average 10 years before MS induced preclinical neuroaxonal damage

Journal of Neurology Neurosurgery & Psychiatry(2023)10.1136/jnnp-2023-331868

N/A

0DataRank · unranked

14 citations

Viktor Grut, Tomas Bergström, Henrik Zetterberg, Martin Biström, Martin Gunnarsson +11 more

A genetic-epigenetic interplay at 1q21.1 locus underlies CHD1L-mediated vulnerability to primary progressive multiple sclerosis

Nature Communications(2024)10.1038/s41467-024-50794-z

N/A

0DataRank · unranked

22 citations

Antonino Giordano, Chiara Starvaggi Cucuzza, Tejaswi V. S. Badam, Samudyata Samudyata, Marianne Victoria Lemée +22 more

Antibody reactivity against EBNA1 and GlialCAM differentiates multiple sclerosis patients from healthy controls

Proceedings of the National Academy of Sciences(2025)10.1073/pnas.2424986122

N/A

0DataRank · unranked

46 citations

Ingrid Kockum, Olivia Thomas, Yicong Liu, Peggy P. Ho, Alison K. Barrett +9 more

Breastfeeding is associated with reduced risk of multiple sclerosis in males, predominantly among HLA-DRB1*15:01 carriers

Multiple Sclerosis Journal - Experimental Translational and Clinical(2020)10.1177/2055217320928101

N/A

0DataRank · unranked

10 citations

Cameron Adams, Xiaoqing Shao, Catherine Schaefer, Tomas Olsson, LF Barcellos +2 more

Treatment- and population-specific genetic risk factors for anti-drug antibodies against interferon-beta

medRxiv(2020)10.1101/2020.05.01.20086033

N/A

0DataRank · unranked

0 citations

Jenny Link, Dorothea Martin, Malin Ryner, Christina Hermanrud, Verena Grummel +16 more

Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease

JAMA Neurology(2021)10.1001/jamaneurol.2021.1858

N/A

0DataRank · unranked

317 citations

Ruben Smith, Niklas Mattsson, Colin Groot, Antoine Leuzy, Olof Strandberg +23 more